Mustafa Khasraw
Mustafa Khasraw
Verified email at
Cited by
Cited by
Advances in the treatment of malignant gliomas
M Khasraw, AB Lassman
Current oncology reports 12 (1), 26-33, 2010
Antiangiogenic therapy for high‐grade glioma
M Khasraw, MS Ameratunga, R Grant, H Wheeler, N Pavlakis
Cochrane Database of Systematic Reviews, 2014
Epirubicin: is it like doxorubicin in breast cancer? A clinical review
M Khasraw, R Bell, C Dang
The Breast 21 (2), 142-149, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
A Omuro, TA Chan, LE Abrey, M Khasraw, AS Reiner, TJ Kaley, ...
Neuro-oncology 15 (2), 242-250, 2013
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
ST Garber, Y Hashimoto, SP Weathers, J Xiu, Z Gatalica, RGW Verhaak, ...
Neuro-oncology 18 (10), 1357-1366, 2016
EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model
T Wang, MP Gantier, D Xiang, AG Bean, M Bruce, SF Zhou, M Khasraw, ...
Theranostics 5 (12), 1456, 2015
Neurological complications of systemic cancer
M Khasraw, JB Posner
The Lancet Neurology 9 (12), 1214-1227, 2010
Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience
M Khasraw, A Holodny, SA Goldlust, LM DeAngelis
Annals of oncology 23 (2), 458-463, 2012
Dual somatostatin receptor/FDG PET/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance
DLH Chan, N Pavlakis, GP Schembri, EJ Bernard, E Hsiao, A Hayes, ...
Theranostics 7 (5), 1149, 2017
Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry
S Gupta, T Tran, W Luo, D Phung, RL Kennedy, A Broad, D Campbell, ...
BMJ open 4 (3), 2014
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer
M Khasraw, N Pavlakis, S McCowatt, C Underhill, S Begbie, P de Souza, ...
Annals of oncology 21 (6), 1302-1307, 2010
Adaptive global innovative learning environment for glioblastoma: GBM AGILE
BM Alexander, S Ba, MS Berger, DA Berry, WK Cavenee, SM Chang, ...
Clinical Cancer Research 24 (4), 737-743, 2018
The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?
M Khasraw, E Brogi, AD Seidman
Current oncology reports 13 (1), 17-25, 2011
Using lithium as a neuroprotective agent in patients with cancer
M Khasraw, D Ashley, G Wheeler, M Berk
BMC medicine 10 (1), 131, 2012
Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?
M Khasraw, D Bell, H Wheeler
Journal of Clinical Neuroscience 16 (6), 854-855, 2009
Small bowel video capsule endoscopy: an overview
BF Mustafa, M Samaan, L Langmead, M Khasraw
Expert review of gastroenterology & hepatology 7 (4), 323-329, 2013
Response to cetuximab with or without irinotecan in patients with refractory metastatic colorectal cancer harboring the KRAS G13D mutation: Australasian Gastro-Intestinal …
E Segelov, S Thavaneswaran, PM Waring, J Desai, KP Robledo, ...
Journal of Clinical Oncology 34 (19), 2258-2264, 2016
Bevacizumab for the treatment of high-grade glioma: an update after phase III trials
M Khasraw, M Ameratunga, C Grommes
Expert opinion on biological therapy 14 (5), 729-740, 2014
Emerging pharmacotherapy for cancer patients with cognitive dysfunction
J Davis, FM Ahlberg, M Berk, DM Ashley, M Khasraw
BMC neurology 13 (1), 153, 2013
Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer
SM Domchek, K Jhaveri, S Patil, JE Stopfer, C Hudis, J Powers, Z Stadler, ...
Cancer 119 (7), 1344-1348, 2013
The system can't perform the operation now. Try again later.
Articles 1–20